Levi & Korsinsky Notifies Shareholders of DICK’s Sporting Goods(DKS) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, March 6, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in DICK’s Sporting Goods (“DICK’s Sporting Goods” or the “Company”) (NYSE: DKS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on
International Defence Authorities Directory 2024
DUBLIN, March 6, 2024 /PRNewswire/ — The “International Directory of Defence Authorities 2024” directory has been added to ResearchAndMarkets.com’s offering. The International Directory of Defence Authorities lets you identify and contact the senior officials that oversee t
Senior Market Sales® Acquires Seniors Advisory Services, Louisiana’s Largest Senior Insurance Brokerage
Agency Plans to Leverage SMS Technology, Products and Expertise to Grow Regionally OMAHA, Neb., March 6, 2024 /PRNewswire/ — Senior Market Sales® (SMS), one of the industry’s premier insurance marketing organizations, is expanding its distribution in the southern United States with the
Dada Nexus Limited Class Action: Levi & Korsinsky Reminds Dada Nexus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 11, 2024 – DADA
NEW YORK, March 6, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Dada Nexus Limited (“Dada Nexus” or the “Company”) (NASDAQ: DADA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Dada Nexus
Gradient Denervation Technologies Enrolls First Patient in Early Feasibility Study of Pulmonary Artery Denervation System
FDA-Approved US study intended to evaluate pulmonary artery denervation in heart failure patients with WHO Group 2 Pulmonary Hypertension PARIS, March 6, 2024 /PRNewswire/ — Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive, ultrasound-ba
Levi & Korsinsky Notifies Shareholders of BioNTech SE(BNTX) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, March 6, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in BioNTech SE (“BioNTech” or the “Company”) (NASDAQ: BNTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioNTech investors wh
MEDIA ADVISORY – Minister Wilkinson to Participate in PDAC 2024
OTTAWA, ON, March 6, 2024 /CNW/ – The Minister of Energy and Natural Resources, the Honourable Jonathan Wilkinson, will hold a call-back with Canadian media to wrap up his participation at the Prospectors and Developers Association of Canada Convention (PDAC) 2024. Date: March 6, 2024Time:
Eurelectric: Break down data silos to accelerate e-mobility
BRUSSELS, March 6, 2024 /PRNewswire/ — Electric vehicle (EV) sales will surpass traditional vehicles by 2030 shows Eurelectric-EY’s new e-mobility report. The EU is doubling down on transport electrification which is set to quadruple by 2040 to decarbonise the sector, according to the C
Akeso Announced the First Patient Dosed in Phase III Trial of Cadonilimab(PD-1/CTLA-4) Combined with Chemotherapy versus Tislelizumab Combined with Chemotherapy in First-line Treatment of PD-L1 negative NSCLC
HONG KONG, March 6, 2024 /PRNewswire/ — Akeso Inc. (“Akeso”, 9926. HK) announced the enrollment of the first patient in the registrational Phase III clinical study comparing Cadonilimab (PD-1/CTLA-4 bispecific antibody) combined with chemotherapy versus Tislelizumab (PD-1 antibo
AIA Carnival Celebrates Grand Finale after returning to the Central Harbourfront for the first time in four years
HONG KONG, March 6, 2024 /PRNewswire/ — The AIA Carnival, Hong Kong’s beloved winter festival, has come to a successful close after making its triumphant return to the Hong Kong harbourfront, captivating the city with its unique and exciting presence. Since its opening on 21st December,
